IBDEI0M9 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10006,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10006,1,3,0)
;;=3^Dementia in Oth Diseases Classd Elswhr w/ Behavioral Disturbances
;;^UTILITY(U,$J,358.3,10006,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10006,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10007,0)
;;=F02.80^^39^421^12
;;^UTILITY(U,$J,358.3,10007,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10007,1,3,0)
;;=3^Dementia in Oth Diseases Classd Elswhr w/o Behavioral Disturbances
;;^UTILITY(U,$J,358.3,10007,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10007,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10008,0)
;;=F03.91^^39^421^13
;;^UTILITY(U,$J,358.3,10008,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10008,1,3,0)
;;=3^Dementia w/ Behavioral Disturbances,Unspec
;;^UTILITY(U,$J,358.3,10008,1,4,0)
;;=4^F03.91
;;^UTILITY(U,$J,358.3,10008,2)
;;=^5133350
;;^UTILITY(U,$J,358.3,10009,0)
;;=G31.83^^39^421^14
;;^UTILITY(U,$J,358.3,10009,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10009,1,3,0)
;;=3^Dementia w/ Lewy Bodies
;;^UTILITY(U,$J,358.3,10009,1,4,0)
;;=4^G31.83
;;^UTILITY(U,$J,358.3,10009,2)
;;=^329888
;;^UTILITY(U,$J,358.3,10010,0)
;;=F01.51^^39^421^30
;;^UTILITY(U,$J,358.3,10010,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10010,1,3,0)
;;=3^Vascular Dementia w/ Behavioral Disturbances
;;^UTILITY(U,$J,358.3,10010,1,4,0)
;;=4^F01.51
;;^UTILITY(U,$J,358.3,10010,2)
;;=^5003047
;;^UTILITY(U,$J,358.3,10011,0)
;;=F01.50^^39^421^31
;;^UTILITY(U,$J,358.3,10011,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10011,1,3,0)
;;=3^Vascular Dementia w/o Behavioral Disturbances
;;^UTILITY(U,$J,358.3,10011,1,4,0)
;;=4^F01.50
;;^UTILITY(U,$J,358.3,10011,2)
;;=^5003046
;;^UTILITY(U,$J,358.3,10012,0)
;;=A81.9^^39^421^6
;;^UTILITY(U,$J,358.3,10012,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10012,1,3,0)
;;=3^Atypical Virus Infection of CNS,Unspec
;;^UTILITY(U,$J,358.3,10012,1,4,0)
;;=4^A81.9
;;^UTILITY(U,$J,358.3,10012,2)
;;=^5000414
;;^UTILITY(U,$J,358.3,10013,0)
;;=A81.09^^39^421^8
;;^UTILITY(U,$J,358.3,10013,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10013,1,3,0)
;;=3^Creutzfeldt-Jakob Disease NEC
;;^UTILITY(U,$J,358.3,10013,1,4,0)
;;=4^A81.09
;;^UTILITY(U,$J,358.3,10013,2)
;;=^5000410
;;^UTILITY(U,$J,358.3,10014,0)
;;=A81.00^^39^421^9
;;^UTILITY(U,$J,358.3,10014,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10014,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Unspec
;;^UTILITY(U,$J,358.3,10014,1,4,0)
;;=4^A81.00
;;^UTILITY(U,$J,358.3,10014,2)
;;=^5000409
;;^UTILITY(U,$J,358.3,10015,0)
;;=A81.01^^39^421^10
;;^UTILITY(U,$J,358.3,10015,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10015,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Variant
;;^UTILITY(U,$J,358.3,10015,1,4,0)
;;=4^A81.01
;;^UTILITY(U,$J,358.3,10015,2)
;;=^336701
;;^UTILITY(U,$J,358.3,10016,0)
;;=A81.89^^39^421^7
;;^UTILITY(U,$J,358.3,10016,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10016,1,3,0)
;;=3^Atypical Virus Infections of CNS NEC
;;^UTILITY(U,$J,358.3,10016,1,4,0)
;;=4^A81.89
;;^UTILITY(U,$J,358.3,10016,2)
;;=^5000413
;;^UTILITY(U,$J,358.3,10017,0)
;;=A81.2^^39^421^27
;;^UTILITY(U,$J,358.3,10017,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10017,1,3,0)
;;=3^Progressive Multifocal Leukoencephalopathy
;;^UTILITY(U,$J,358.3,10017,1,4,0)
;;=4^A81.2
;;^UTILITY(U,$J,358.3,10017,2)
;;=^5000411
;;^UTILITY(U,$J,358.3,10018,0)
;;=B20.^^39^421^17
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0M9 3775 printed Apr 09, 2024@21:11:58 Page 2
IBDEI0M9 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10006,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,10006,1,3,0)
+4 ;;=3^Dementia in Oth Diseases Classd Elswhr w/ Behavioral Disturbances
+5 ;;^UTILITY(U,$J,358.3,10006,1,4,0)
+6 ;;=4^F02.81
+7 ;;^UTILITY(U,$J,358.3,10006,2)
+8 ;;=^5003049
+9 ;;^UTILITY(U,$J,358.3,10007,0)
+10 ;;=F02.80^^39^421^12
+11 ;;^UTILITY(U,$J,358.3,10007,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,10007,1,3,0)
+14 ;;=3^Dementia in Oth Diseases Classd Elswhr w/o Behavioral Disturbances
+15 ;;^UTILITY(U,$J,358.3,10007,1,4,0)
+16 ;;=4^F02.80
+17 ;;^UTILITY(U,$J,358.3,10007,2)
+18 ;;=^5003048
+19 ;;^UTILITY(U,$J,358.3,10008,0)
+20 ;;=F03.91^^39^421^13
+21 ;;^UTILITY(U,$J,358.3,10008,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,10008,1,3,0)
+24 ;;=3^Dementia w/ Behavioral Disturbances,Unspec
+25 ;;^UTILITY(U,$J,358.3,10008,1,4,0)
+26 ;;=4^F03.91
+27 ;;^UTILITY(U,$J,358.3,10008,2)
+28 ;;=^5133350
+29 ;;^UTILITY(U,$J,358.3,10009,0)
+30 ;;=G31.83^^39^421^14
+31 ;;^UTILITY(U,$J,358.3,10009,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,10009,1,3,0)
+34 ;;=3^Dementia w/ Lewy Bodies
+35 ;;^UTILITY(U,$J,358.3,10009,1,4,0)
+36 ;;=4^G31.83
+37 ;;^UTILITY(U,$J,358.3,10009,2)
+38 ;;=^329888
+39 ;;^UTILITY(U,$J,358.3,10010,0)
+40 ;;=F01.51^^39^421^30
+41 ;;^UTILITY(U,$J,358.3,10010,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,10010,1,3,0)
+44 ;;=3^Vascular Dementia w/ Behavioral Disturbances
+45 ;;^UTILITY(U,$J,358.3,10010,1,4,0)
+46 ;;=4^F01.51
+47 ;;^UTILITY(U,$J,358.3,10010,2)
+48 ;;=^5003047
+49 ;;^UTILITY(U,$J,358.3,10011,0)
+50 ;;=F01.50^^39^421^31
+51 ;;^UTILITY(U,$J,358.3,10011,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,10011,1,3,0)
+54 ;;=3^Vascular Dementia w/o Behavioral Disturbances
+55 ;;^UTILITY(U,$J,358.3,10011,1,4,0)
+56 ;;=4^F01.50
+57 ;;^UTILITY(U,$J,358.3,10011,2)
+58 ;;=^5003046
+59 ;;^UTILITY(U,$J,358.3,10012,0)
+60 ;;=A81.9^^39^421^6
+61 ;;^UTILITY(U,$J,358.3,10012,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,10012,1,3,0)
+64 ;;=3^Atypical Virus Infection of CNS,Unspec
+65 ;;^UTILITY(U,$J,358.3,10012,1,4,0)
+66 ;;=4^A81.9
+67 ;;^UTILITY(U,$J,358.3,10012,2)
+68 ;;=^5000414
+69 ;;^UTILITY(U,$J,358.3,10013,0)
+70 ;;=A81.09^^39^421^8
+71 ;;^UTILITY(U,$J,358.3,10013,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,10013,1,3,0)
+74 ;;=3^Creutzfeldt-Jakob Disease NEC
+75 ;;^UTILITY(U,$J,358.3,10013,1,4,0)
+76 ;;=4^A81.09
+77 ;;^UTILITY(U,$J,358.3,10013,2)
+78 ;;=^5000410
+79 ;;^UTILITY(U,$J,358.3,10014,0)
+80 ;;=A81.00^^39^421^9
+81 ;;^UTILITY(U,$J,358.3,10014,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,10014,1,3,0)
+84 ;;=3^Creutzfeldt-Jakob Disease,Unspec
+85 ;;^UTILITY(U,$J,358.3,10014,1,4,0)
+86 ;;=4^A81.00
+87 ;;^UTILITY(U,$J,358.3,10014,2)
+88 ;;=^5000409
+89 ;;^UTILITY(U,$J,358.3,10015,0)
+90 ;;=A81.01^^39^421^10
+91 ;;^UTILITY(U,$J,358.3,10015,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,10015,1,3,0)
+94 ;;=3^Creutzfeldt-Jakob Disease,Variant
+95 ;;^UTILITY(U,$J,358.3,10015,1,4,0)
+96 ;;=4^A81.01
+97 ;;^UTILITY(U,$J,358.3,10015,2)
+98 ;;=^336701
+99 ;;^UTILITY(U,$J,358.3,10016,0)
+100 ;;=A81.89^^39^421^7
+101 ;;^UTILITY(U,$J,358.3,10016,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,10016,1,3,0)
+104 ;;=3^Atypical Virus Infections of CNS NEC
+105 ;;^UTILITY(U,$J,358.3,10016,1,4,0)
+106 ;;=4^A81.89
+107 ;;^UTILITY(U,$J,358.3,10016,2)
+108 ;;=^5000413
+109 ;;^UTILITY(U,$J,358.3,10017,0)
+110 ;;=A81.2^^39^421^27
+111 ;;^UTILITY(U,$J,358.3,10017,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,10017,1,3,0)
+114 ;;=3^Progressive Multifocal Leukoencephalopathy
+115 ;;^UTILITY(U,$J,358.3,10017,1,4,0)
+116 ;;=4^A81.2
+117 ;;^UTILITY(U,$J,358.3,10017,2)
+118 ;;=^5000411
+119 ;;^UTILITY(U,$J,358.3,10018,0)
+120 ;;=B20.^^39^421^17
